Universe Pharmaceuticals (NASDAQ:UPC) Trading Down 2.4% – What’s Next?

Shares of Universe Pharmaceuticals INC (NASDAQ:UPC) fell 2.4% on Tuesday . The stock traded as low as $3.60 and last traded at $3.60. 17,931 shares were traded during trading, a decline of 35% from the average session volume of 27,418 shares. The stock had previously closed at $3.69.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Universe Pharmaceuticals in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Universe Pharmaceuticals Stock Performance

The company has a current ratio of 2.78, a quick ratio of 2.62 and a debt-to-equity ratio of 0.04. The stock’s 50 day moving average price is $4.71.

Universe Pharmaceuticals Company Profile

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.